Search Results Search Sort by RelevanceMost Recent Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.